Dr. Frank Luh, CEO of the Sino-American Cancer Foundation (SACF), will speak at the ISPE Greater Los Angeles Chapter’s Executive Night 2025, hosted by Takeda in March 2025.
A leader in cancer research and biopharma innovation, Dr. Luh has driven advancements in oncology, translational medicine, and cell therapies. His work at SACF fosters collaboration between academia, biotech, and healthcare institutions, accelerating cancer drug discovery and precision medicine.
At this exclusive event, he will join industry leaders to discuss pharmaceutical engineering and manufacturing challenges, offering insights into the future of oncology drug development.
Stay tuned for key takeaways from his talk!
